This massive acquisition, expected to close in 2026, will require significant integration of systems, processes, and personnel.
Filing excerpt
On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc. (Penumbra), a publicly traded medical technology company primarily focused on innovative medical thrombectomy products for use in peripheral vascular procedures in the removal of blood clots and blockages.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Technologies
sec-10kacquisitionAnnouncedGet every 10-K signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/42618a5b-619f-4530-8a8e-b039336830ff returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "42618a5b-619f-4530-8a8e-b039336830ff",
"signal_type": "sec-10k",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-02-24T09:19:12.736+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "This massive acquisition, expected to close in 2026, will require significant integration of systems, processes, and personnel. The company is taking on substantial debt, creating pressure to realize synergies and ROI quickly, opening opportunities for vendors in M&A integration, financial systems, and operational efficiency.",
"metrics": {
"timeframe": "next_year",
"dollar_context": "Purchase price for Penumbra, Inc. acquisition",
"dollar_millions": 14500
},
"summary": "Announced definitive agreement to acquire Penumbra for $14.5B, funded by $11B in new debt.",
"excerpts": "On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc. (Penumbra), a publicly traded medical technology company primarily focused on innovative medical thrombectomy products for use in peripheral vascular procedures in the removal of blood clots and blockages.",
"relevance": 1,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000010/bsx-20251231.htm",
"filing_date": "2026-02-17",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic",
"technologies_mentioned": [
"thrombectomy",
"Computer Assisted Vacuum Thrombectomy (CAVT™)"
]
}
}
curl https://signals.autobound.ai/v1/signals/42618a5b-619f-4530-8a8e-b039336830ff \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.